20 August 2019 - PHARMAC’s model and budget is under intense scrutiny, as the Government prepares to announce its interim cancer action plan.
Modern medicine has led to an explosion in the number of treatments available, especially when it comes to cancer drugs.
This has led to growing calls from patients and drug companies to publicly fund these medicines, coupled with intense scrutiny of PHARMAC’s model, processes and fixed budget.